Jitendra Wadhane - 25 Sep 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Chief Accounting Officer
Signature
/s/ Jitendra Wadhane
Issuer symbol
PYXS
Transactions as of
25 Sep 2023
Net transactions value
+$8,850
Form type
4
Filing time
25 Sep 2023, 17:05:30 UTC
Previous filing
22 Sep 2023
Next filing
27 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Purchase $8,850 +5,000 +2.3% $1.77 224,437 25 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased all 5,000 shares of common stock in the open market at a price of $1.77 per share.